6,531 followers
New research: Case Report: PD-L1-negative advanced bladder cancer effectively treated with anlotinib and tislelizumab: A report of two cases: Second-line treatment for metastatic or locally advanced urothelial cancer (UC) is limited.… https://t.co/Z5PXe4hB